BRPI0819991A2 - Derivados de indolinona e processo para fabricação dos mesmos - Google Patents

Derivados de indolinona e processo para fabricação dos mesmos

Info

Publication number
BRPI0819991A2
BRPI0819991A2 BRPI0819991A BRPI0819991A2 BR PI0819991 A2 BRPI0819991 A2 BR PI0819991A2 BR PI0819991 A BRPI0819991 A BR PI0819991A BR PI0819991 A2 BRPI0819991 A2 BR PI0819991A2
Authority
BR
Brazil
Prior art keywords
manufacturing process
indolinone derivatives
indolinone
derivatives
manufacturing
Prior art date
Application number
Other languages
English (en)
Inventor
Joern Merten
Svenja Renner
Carsten Reichel
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40718253&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0819991(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of BRPI0819991A2 publication Critical patent/BRPI0819991A2/pt
Publication of BRPI0819991B1 publication Critical patent/BRPI0819991B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI0819991-4A 2007-12-03 2008-12-02 Derivados de indolinona e processo para fabricação dos mesmos BRPI0819991B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07122123.8 2007-12-03
EP07122123 2007-12-03
PCT/EP2008/066581 WO2009071524A2 (en) 2007-12-03 2008-12-02 Indolinone derivatives and process for their manufacture

Publications (2)

Publication Number Publication Date
BRPI0819991A2 true BRPI0819991A2 (pt) 2015-05-12
BRPI0819991B1 BRPI0819991B1 (pt) 2022-02-15

Family

ID=40718253

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0819991-4A BRPI0819991B1 (pt) 2007-12-03 2008-12-02 Derivados de indolinona e processo para fabricação dos mesmos

Country Status (36)

Country Link
US (1) US8067617B2 (pt)
EP (1) EP2229360B1 (pt)
JP (2) JP5933924B2 (pt)
KR (2) KR101676261B1 (pt)
CN (1) CN101883755B (pt)
AR (1) AR069531A1 (pt)
AU (1) AU2008333287B2 (pt)
BR (1) BRPI0819991B1 (pt)
CA (1) CA2705490C (pt)
CL (1) CL2008003599A1 (pt)
CO (1) CO6210751A2 (pt)
CY (1) CY1123333T1 (pt)
DK (1) DK2229360T3 (pt)
EA (1) EA016196B1 (pt)
EC (1) ECSP10010195A (pt)
ES (1) ES2818993T3 (pt)
HK (1) HK1145682A1 (pt)
HR (1) HRP20201480T1 (pt)
HU (1) HUE051550T2 (pt)
IL (1) IL205348A (pt)
LT (1) LT2229360T (pt)
MA (1) MA31989B1 (pt)
MX (1) MX2010005557A (pt)
MY (1) MY148574A (pt)
NZ (1) NZ585798A (pt)
PE (1) PE20091445A1 (pt)
PL (1) PL2229360T3 (pt)
PT (1) PT2229360T (pt)
RS (1) RS60818B1 (pt)
SI (1) SI2229360T1 (pt)
TN (1) TN2010000248A1 (pt)
TW (1) TWI432415B (pt)
UA (1) UA97872C2 (pt)
UY (1) UY31506A1 (pt)
WO (1) WO2009071524A2 (pt)
ZA (1) ZA201002723B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY31506A1 (es) * 2007-12-03 2009-08-03 Derivados de indolinona y procedimiento para su preparacion
US20170065529A1 (en) 2015-09-09 2017-03-09 Boehringer Ingelheim International Gmbh Pharmaceutical dosage form for immediate release of an indolinone derivative
WO2012068441A2 (en) 2010-11-19 2012-05-24 Ratiopharm Gmbh Intedanib salts and solid state forms thereof
CN103787949A (zh) * 2012-10-31 2014-05-14 韩冰 一类保护移植器官的化合物及其用途
US20140350022A1 (en) 2013-05-10 2014-11-27 Boehringer Ingelheim International Gmbh Efficacious treatment of NSCLC and predictive clinical marker of the responsiveness of a tumour to a treatment
CA3172586A1 (en) 2013-07-31 2015-02-05 Avalyn Pharma Inc. Aerosol imatininb compounds and uses thereof
US20140342772A1 (en) * 2013-09-12 2014-11-20 Bandwidth.Com, Inc. Predictive Caching of IP Data
CN104262232B (zh) * 2014-09-09 2016-05-04 苏州明锐医药科技有限公司 尼泰达尼的制备方法
CN105712923A (zh) * 2014-12-03 2016-06-29 江苏先声药业有限公司 一种尼达尼布杂质及其制备方法与应用
WO2016178064A1 (en) 2015-05-06 2016-11-10 Suven Life Sciences Limited Polymorph of nintedanib ethanesulphonate, processes and intermediates thereof
CN105001143A (zh) * 2015-07-24 2015-10-28 南京正大天晴制药有限公司 一种制备高纯度乙磺酸尼达尼布的方法
WO2017077551A2 (en) 2015-11-03 2017-05-11 Mylan Laboratories Limited An amorphous nintedanib esylate and solid dispersion thereof
CN109415314A (zh) * 2016-05-19 2019-03-01 上海诚妙医药科技有限公司 尼达尼布的新晶型及其制备方法及其用途
CN106543069A (zh) * 2016-09-20 2017-03-29 北京万全德众医药生物技术有限公司 6‑甲氧基羰基‑2‑氧代二氢吲哚的制备
CN108610308A (zh) * 2016-12-09 2018-10-02 上海奥博生物医药技术有限公司 一锅法制备尼达尼布中间体的方法
CN106841495B (zh) * 2017-04-21 2018-05-11 常州佳德医药科技有限公司 乙磺酸尼达尼布中基因毒性杂质的高灵敏度分析方法
WO2019048974A1 (en) * 2017-09-06 2019-03-14 Glenmark Pharmaceuticals Limited PROCESS FOR PREPARING NINTEDANIB
CA3082714A1 (en) 2017-11-17 2019-05-23 Fermion Oy Synthesis of a 2-indolinone derivative known as intermediate for preparing nintedanib
CN110746378B (zh) * 2018-12-03 2021-11-05 江苏豪森药业集团有限公司 一种胺基中间体的制备方法
CN111377845A (zh) * 2018-12-27 2020-07-07 江苏先声药业有限公司 3-(二甲氨基(苯基)亚甲基)-2-氧化吲哚-6-羧酸甲酯及其制备方法与应用
CN111662223B (zh) * 2019-03-08 2023-07-14 四川科伦药物研究院有限公司 二氢吲哚酮衍生物及其中间体的制备方法
US20240051920A1 (en) * 2020-08-07 2024-02-15 Bdr Lifesciences Private Limited An improved highly efficient process for the preparation of nintedanib and pharmaceutically acceptable salt thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4876863A (pt) * 1972-01-22 1973-10-16
US6469181B1 (en) * 1995-01-30 2002-10-22 Catalytica, Inc. Process for preparing 2-oxindoles and N-hydroxy-2-oxindoles
GB9516943D0 (en) * 1995-08-18 1995-10-18 Cancer Soc Auckland Div Nz Inc Novel cyclopropylindoles and their secoprecursors,and their use as prodrugs
DK1115704T3 (da) 1998-09-25 2003-09-29 Boehringer Ingelheim Pharma Substituerede indolinoner med inhiberende virkning for forskellige kinaser og cyclin/CDK komplekser
US7291641B2 (en) * 1999-10-11 2007-11-06 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
UA75054C2 (uk) * 1999-10-13 2006-03-15 Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг Заміщені в положенні 6 індолінони, їх одержання та їх застосування як лікарського засобу
DE10117204A1 (de) * 2001-04-06 2002-10-10 Boehringer Ingelheim Pharma In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
DE10233500A1 (de) * 2002-07-24 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylen]-6-methoxycarbonyl-2-indolinon-Monoethansulfonat und dessen Verwendung als Arzneimittel
US7148249B2 (en) * 2002-09-12 2006-12-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
WO2008056634A1 (fr) * 2006-11-06 2008-05-15 Theravalues Corporation Nouveau dérivé d'hydroxyindole
UY31506A1 (es) * 2007-12-03 2009-08-03 Derivados de indolinona y procedimiento para su preparacion
AR069530A1 (es) * 2007-12-03 2010-01-27 Boehringer Ingelheim Int Procedimiento para la fabricacion de un derivado de indolinona

Also Published As

Publication number Publication date
TWI432415B (zh) 2014-04-01
KR101676261B1 (ko) 2016-11-15
WO2009071524A3 (en) 2009-10-01
JP6044025B2 (ja) 2016-12-14
CO6210751A2 (es) 2010-10-20
EA201000883A1 (ru) 2010-12-30
JP5933924B2 (ja) 2016-06-15
HRP20201480T1 (hr) 2020-12-11
TN2010000248A1 (fr) 2011-11-11
BRPI0819991B1 (pt) 2022-02-15
EA016196B1 (ru) 2012-03-30
ECSP10010195A (es) 2010-07-30
US20100311985A1 (en) 2010-12-09
WO2009071524A2 (en) 2009-06-11
IL205348A0 (en) 2010-12-30
CA2705490C (en) 2016-02-02
CL2008003599A1 (es) 2010-08-20
DK2229360T3 (da) 2020-09-28
MA31989B1 (fr) 2011-01-03
PL2229360T3 (pl) 2020-12-14
UA97872C2 (ru) 2012-03-26
KR20100097129A (ko) 2010-09-02
RS60818B1 (sr) 2020-10-30
HK1145682A1 (en) 2011-04-29
CA2705490A1 (en) 2009-06-11
AU2008333287A1 (en) 2009-06-11
KR101712810B1 (ko) 2017-03-07
ZA201002723B (en) 2010-12-29
MY148574A (en) 2013-04-30
CN101883755A (zh) 2010-11-10
HUE051550T2 (hu) 2021-03-01
JP2011505346A (ja) 2011-02-24
LT2229360T (lt) 2020-10-12
IL205348A (en) 2014-06-30
AR069531A1 (es) 2010-01-27
KR20150116909A (ko) 2015-10-16
EP2229360B1 (en) 2020-07-01
JP2015071602A (ja) 2015-04-16
EP2229360A2 (en) 2010-09-22
CY1123333T1 (el) 2021-12-31
ES2818993T3 (es) 2021-04-14
CN101883755B (zh) 2013-06-26
MX2010005557A (es) 2010-06-01
TW200930702A (en) 2009-07-16
US8067617B2 (en) 2011-11-29
NZ585798A (en) 2011-06-30
SI2229360T1 (sl) 2020-11-30
UY31506A1 (es) 2009-08-03
AU2008333287B2 (en) 2013-12-19
PT2229360T (pt) 2020-09-15
PE20091445A1 (es) 2009-10-19

Similar Documents

Publication Publication Date Title
BRPI0819991A2 (pt) Derivados de indolinona e processo para fabricação dos mesmos
BRPI0810632A2 (pt) Derivados de piridopirazina, processo de fabricação e usos dos mesmos
FI20075978A0 (fi) Järjestely ja menetelmä
BRPI0808800A2 (pt) elementos de cerâmicas de alta resistência e processo para fabricação e utilização dos mesmos
BRPI0809681A2 (pt) processo para fabricação de polímeros
BRPI0822705A2 (pt) Painel de ligações impresso e método para fabricar o mesmo
BRPI0921106A2 (pt) biocombustível e processo para preparação de biocombustível
BRPI0819182A2 (pt) Polímero, proceso para preparar o mesmo, derivados, e, processo para preparar os mesmos
BRPI0821944A2 (pt) Processo
BRPI0920414A2 (pt) Processo para a produção de alfa-tocotrienal e seus derivados
BRPI0919868A2 (pt) processo
BRPI0916588A2 (pt) cobertor, produtos correlacionados e métodos de produção dos mesmos
BRPI0810850A2 (pt) Processo para carbonilação de dimetil éter
BRPI0716009A2 (pt) Aparelho e processo para produção de etanol
FI20065348A0 (fi) Spektrometri ja inferferometrinen menetelmä
BRPI0810846A2 (pt) Processo para carbonilção de dimetil éter
BRPI0716479A2 (pt) Processo sol-gel
BRPI0813660A2 (pt) Processo para o cultivo de microalgas
BRPI0818820A2 (pt) Processo para continuamente produzir derivados de 3-isotiazoinona e produtos intermediários dos mesmos
BRPI0816911A2 (pt) Processo para preparação de 4-aminobut-2-enolidas
BRPI0921374A2 (pt) processo
BRPI0921532A2 (pt) dispositivo distribuidor de potencial para distribuição de potencial e processo para distribuição de potencial
BRPI0914221A2 (pt) processo, e, composto
BRPI0813960A2 (pt) Processo para produção de biarilas
BRPI0910939A2 (pt) dispositivo estabilizador e processo de produção do mesmo

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: C07D 209/34

Ipc: C07D 209/34 (2006.01), A61P 35/00 (2006.01)

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/12/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.